Delivery Order SPE2DB20D3103-SPE2DB21FN3P8

Award Date 4/20/21
Potential Completion Date 4/21/21
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chesterbrook, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,722.50 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,714.22 for pharmaceutical and medical supply distribution. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 3, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,496.18 issued by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, syringes, vials, and other critical care materials to support military treatment...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,044.96 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of various pharmaceutical products and medical supplies, primarily to support military and veteran healthcare programs. The contract, valued at $5,745.04, is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $12,512.55 for pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $9,329.76, awarded by the Defense Logistics Agency (DLA) for pharmaceutical products and medical supplies. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
This federal contract award, valued at $468,050.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order to provide pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and various medical devices and equipment. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of a range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The contract, valued at $1,287.81, is a delivery order issued under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $3,129.64 for pharmaceutical and medical supply products. The contract was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FN3P8
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $1,916.28, is a delivery order awarded by the Defense Logistics Agency (DLA) for pharmaceutical and medical supplies. The contract has no set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 2/27/25, 11:20 AM